0001562180-24-004462.txt : 20240528
0001562180-24-004462.hdr.sgml : 20240528
20240528162248
ACCESSION NUMBER: 0001562180-24-004462
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240525
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elston George
CENTRAL INDEX KEY: 0001429932
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 24992165
MAIL ADDRESS:
STREET 1: 124 CHATHAM STREET
CITY: CHATHAM
STATE: NJ
ZIP: 07928
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-05-25
false
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001429932
Elston George
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
false
true
false
false
Chief Financial Officer
false
Common Stock
2024-05-25
4
M
false
7500.00
0.00
A
51107.00
D
Common Stock
2024-05-25
4
F
false
3627.00
11.16
D
47480.00
D
Restricted Stock Units
0.00
2024-05-25
4
M
false
7500.00
0.00
D
Common Stock
7500.00
15000.00
D
No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
The restricted stock units vest in three ratable annual installments beginning May 25, 2024.
/s/ Ron Honig, Attorney-in-Fact
2024-05-28